Claus Marsh is an innovation-driven integratepharmaceutical company focusing on the discovery, development and commercialization of prescription medicines, OTC products and medical devices in the following core therapeutic areas namely Gynecology, Neurology, and Ophthalmology. We are also present in the therapeutic areas of infection & vaccines. In 2005, Claus Marsh acquired AltesGroup and expanded its activities into different CIS countries. It ranks among the top ten fastest-growing pharmaceutical companies across the CIS emerging markets and it operates in more than ten nations while simultaneously employing more than 500 employees.